Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014 (2014), Article ID 965971, 6 pages
http://dx.doi.org/10.1155/2014/965971
Research Article

Serum YKL-40 Levels and Chitotriosidase Activity in Patients with Beta-Thalassemia Major

1Center for Integrated Research, Department of Laboratory Medicine and Microbiology, Campus Bio-Medico University of Rome, 00128 Rome, Italy
2Center of Microcitemia, 95123 Catania, Italy
3IRMA, Acireale, 95024 Catania, Italy
4Department of Surgery and Cancer, Parturition Research Group, Institute of Reproduction and Developmental Biology, Imperial College London, London W12 0NN, UK
5Department of Chemical Sciences, University of Catania and Institute of Biomolecular Chemistry, CNR, 95125 Catania, Italy

Received 31 October 2013; Accepted 29 January 2014; Published 8 April 2014

Academic Editor: Yi-Chia Huang

Copyright © 2014 Maria Musumeci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Johansen, “Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer,” Danish Medical Bulletin, vol. 53, no. 2, pp. 172–209, 2006. View at Google Scholar · View at Scopus
  2. M. Rehli, S. W. Krause, and R. Andreesen, “Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation,” Genomics, vol. 43, no. 2, pp. 221–225, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Rehli, H.-H. Niller, C. Ammon et al., “Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation,” Journal of Biological Chemistry, vol. 278, no. 45, pp. 44058–44067, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Junker, J. S. Johansen, C. B. Andersen, and P. E. G. Kristjansen, “Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer,” Lung Cancer, vol. 48, no. 2, pp. 223–231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Volck, J. S. Johansen, M. Stoltenberg et al., “Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology,” Osteoarthritis and Cartilage, vol. 9, no. 3, pp. 203–214, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. J. S. Johansen, B. Baslund, C. Garbarsch et al., “YKL-40 in giant cells and macrophages from patients with giant cell arteritis,” Arthritis & Rheumatology, vol. 42, pp. 2624–2630, 1999. View at Google Scholar
  7. R. G. Boot, T. A. E. Van Achterberg, B. E. Van Aken et al., “Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 3, pp. 687–694, 1999. View at Google Scholar · View at Scopus
  8. G. L. Chupp, C. G. Lee, N. Jarjour et al., “A chitinase-like protein in the lung and circulation of patients with severe asthma,” The New England Journal of Medicine, vol. 357, no. 20, pp. 2016–2027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. Johanshn, S. Møller, P. A. Price et al., “Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?” Scandinavian Journal of Gastroenterology, vol. 32, no. 6, pp. 582–590, 1997. View at Google Scholar · View at Scopus
  10. S. M. Kamal, B. Turner, Q. He et al., “Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis,” Hepatology, vol. 43, no. 4, pp. 771–779, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Pinzani, “Liver fibrosis,” Springer Seminars in Immunopathology, vol. 21, no. 4, pp. 475–490, 1999. View at Google Scholar · View at Scopus
  12. F. de Ceuninck, S. Gaufillier, A. Bonnaud, M. Sabatini, C. Lesur, and P. Pastoureau, “YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes,” Biochemical and Biophysical Research Communications, vol. 285, no. 4, pp. 926–931, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Ling and A. D. Recklies, “The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-α,” Biochemical Journal, vol. 380, no. 3, pp. 651–659, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C. E. M. Hollak, S. van Weely, M. H. J. van Oers, and J. M. F. G. Aerts, “Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease,” Journal of Clinical Investigation, vol. 93, no. 3, pp. 1288–1292, 1994. View at Google Scholar · View at Scopus
  15. Y. Guo, W. He, A. M. Boer et al., “Elevated plasma chitotriosidase activity in various lysosomal storage disorders,” Journal of Inherited Metabolic Disease, vol. 18, no. 6, pp. 717–722, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Barone, J. Simporé, L. Malaguarnera, S. Pignatelli, and S. Musumeci, “Plasma chitotriosidase activity in acute Plasmodium falciparum malaria,” Clinica Chimica Acta, vol. 331, no. 1-2, pp. 79–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Barone, F. Di Gregorio, M. A. Romeo, G. Schilirò, and L. Pavone, “Plasma chitotriosidase activity in patients with β-thalassemia,” Blood Cells, Molecules, and Diseases, vol. 25, no. 1, pp. 1–8, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Borgna-Pignatti and M. R. Gamberini, “Complications of thalassemia major and their treatment,” Expert Review of Hematology, vol. 4, no. 3, pp. 353–366, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Ragab, S. Helal, N. Zaghloul et al., “Clinicovirologic analysis of hepatitis C infection in transfusion-dependent β-thalassemia major children,” International Journal of Laboratory Hematology, vol. 32, no. 2, pp. 184–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Cianciulli, “Treatment of iron overload in thalassemia,” Pediatric Endocrinology Reviews, vol. 6, supplement 1, pp. 208–213, 2008. View at Google Scholar · View at Scopus
  21. R. Barone, G. Bertrand, J. Simporè, M. Malaguarnera, and S. Musumeci, “Plasma chitotriosidase activity in β-thalassemia major: a comparative study between Sicilian and Sardinian patients,” Clinica Chimica Acta, vol. 306, no. 1-2, pp. 91–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Matsumoto and T. Tsurumoto, “Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laboratory parameters,” Clinical and Experimental Rheumatology, vol. 19, no. 6, pp. 655–660, 2001. View at Google Scholar · View at Scopus
  23. T. Rath, M. Roderfeld, C. Gler et al., “YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis,” Scandinavian Journal of Gastroenterology, vol. 46, no. 11, pp. 1369–1380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Huang and L.-D. Wu, “YKL-40: a potential biomarker for osteoarthritis,” Journal of International Medical Research, vol. 37, no. 1, pp. 18–24, 2009. View at Google Scholar · View at Scopus
  25. R. B. Kirkpatrick, J. G. Emery, J. R. Connor, R. Dodds, P. G. Lysko, and M. Rosenberg, “Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages,” Experimental Cell Research, vol. 237, no. 1, pp. 46–54, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. R. G. Boot, T. A. E. Van Achterberg, B. E. Van Aken et al., “Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 3, pp. 687–694, 1999. View at Google Scholar · View at Scopus
  27. K. C. Nishikawa and A. J. T. Millis, “gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells,” Experimental Cell Research, vol. 287, no. 1, pp. 79–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. N. A. Shackel, P. H. McGuinness, C. A. Abbott, M. D. Gorrell, and G. W. McCaughan, “Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization,” Hepatology, vol. 38, no. 3, pp. 577–588, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. S. M. Kamal, B. Turner, Q. He et al., “Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis,” Hepatology, vol. 43, no. 4, pp. 771–779, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Saitou, K. Shiraki, Y. Yamanaka et al., “Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease,” World Journal of Gastroenterology, vol. 11, no. 4, pp. 476–481, 2005. View at Google Scholar · View at Scopus
  31. A. Tran, S. Benzaken, M.-C. Saint-Paul et al., “Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease,” European Journal of Gastroenterology and Hepatology, vol. 12, no. 9, pp. 989–993, 2000. View at Google Scholar · View at Scopus
  32. C. Nøjgaard, J. S. Johansen, E. Christensen, L. T. Skovgaard, P. A. Price, and U. Becker, “Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease,” Journal of Hepatology, vol. 39, no. 2, pp. 179–186, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Wang, R. S. Ripa, J. S. Johansen et al., “YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease,” Scandinavian Cardiovascular Journal, vol. 42, no. 5, pp. 295–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Maccarone, G. Pizzarelli, R. Barone, and S. Musumeci, “Plasma chitotriosidase activity is a marker of recovery in transplanted patients affected by β-thalassemia major,” Acta Haematologica, vol. 105, no. 2, pp. 109–110, 2001. View at Publisher · View at Google Scholar · View at Scopus